Risks and Solutions for High-cost Therapies In the last few years, we have seen novel therapies for some complex, rare, and even previously untreatable diseases being approved – Brineura for a rare disorder of the brain, Luxturna for a specific kind of retinal dystrophy, Zolgensma for spinal muscular atrophy, etc. These drugs offer a huge […]
Introduction A major challenge around recruitment and retention of subjects in clinical trials has been the requirement for them to have easy access to medical centers so they can travel to the trial sites for screening and enrolment, as well as for follow-up visits for tests and procedures required as per the protocol, and medication […]
Value-based healthcare (VBH) as a concept was introduced in 2006 by Porter and Teisberg1, though facets of this concept have been around for much longer. Value-based healthcare delivery model is a framework that encourages healthcare providers to focus on quality than quantity. A look at the different healthcare systems across the globe immediately makes it […]
Actu-Real Inc. and Jehangir Clinical Dev Centre (JCDC) announce their joint initiative J-ARC Healthcare Solutions, a strategic collaboration to further real-world research
Leveraging real-world evidence in clinical development Commentary on the MHRA guidance on the use of real-world data in clinical studies to support regulatory decisions (1) and the MHRA guideline on randomized controlled trials using real-world data to support regulatory decisions (2), both recently published (December 16, 2021) MHRA acknowledges that evidence from randomized trials using […]
Value based healthcare can only make an impact if it can address complicated concerns such as marginal benefits to healthcare, comparative net health outcomes, and most prominently, whether value-based health care is worth it. The good news is we can use current industry methods such as Markov models and cost effectiveness analysis to make a […]
There have been many reactions to the retrospective study identifying sildenafil (Viagra) as a candidate drug for Alzheimer’s disease that has just been published in Nature Aging. Despite alternative explanations (and hidden unknowns) the results are generally viewed as enough evidence of an association to justify prospective studies. One issue that I have not seen […]
A recent article in the November 24 issue of Fierce Healthcare summarizes results from value-based care from the insurer Humana in their latest annual value-based care report. https://www.fiercehealthcare.com/payer/humana-value-based-care-report-better-outcomes-lower-costs?oly_enc_id=6788I8208556H4KI According to Humana, Medicare Advantage (MA) members receiving value-based care had more preventive care, lower costs, and better outcomes in 2020 compared to those in traditional Medicare. […]
Author: Pierre Etienne
Author: Pierre Etienne, Co-Founder and CMO
Introduction: Outcomes-based care and contracting or Value-based pricing or Performance-based risk s...
The concept of risk sharing is fundamental to all insurance products and contracts. At the simplest...
Actu-Real offers solutions and services to help payers, providers and pharmaceutical companies optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization.
